ERBB2 and neoplasm: In contrast to what was seen by our group in the ER-positive disease, the higher rates of Ki67 expression, relatively lower proportion of PR expression and higher proportion of HER2 over-expression (as opposed to the ER positive tumours) in our study (Table 5)are consistent with more aggressive tumour biology as reported in previous studies[14, 17–20].